HIC
IDXX icon

Hamrick Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Hamrick Investment Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Buy
9
+4
+80% +$2.24K ﹤0.01% 156
2026
Q1 		$2.81K Buy
+5
New +$3.21K ﹤0.01% 299

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hamrick Investment Counsel's IDXX Position: Q2 2026 in Review

Hamrick Investment Counsel increased its Idexx Laboratories (IDXX) stake by 80% in Q2 2026, buying an estimated $2.24K and bringing the position to 9 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #156.

Hamrick Investment Counsel first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Hamrick Investment Counsel held 9 shares of Idexx Laboratories worth $4.74K as of Q2 2026.
  • Hamrick Investment Counsel bought 4 Idexx Laboratories shares in Q2 2026, an estimated $2.24K.
  • Idexx Laboratories made up ﹤0.01% of Hamrick Investment Counsel's portfolio in Q2 2026, its #156 holding.
  • Hamrick Investment Counsel first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.